High materiality7/10
BioCryst price target raised to $29 from $27 at Cantor Fitzgerald
Why it may matterVerify against the original reporting
very_bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Cantor Fitzgerald raises BCRX target to $29; current price $9.55.
- Cantor Fitzgerald raises target to $29; price $9.55
Key facts
- 01
Target: $29
- 02
Posted price: $9.55
- 03
Analyst firm: Cantor Fitzgerald
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.